Press release
Gaucher Disease Treatment Market - Global Industry Analysis 2025
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/1225
Approval of novel drugs is expected to boost growth of Gaucher disease treatment market
U.S. Food and Drug Administration (FDA) has approved multiple drugs in last few years for the treatment of disease. In 2010, FDA approved Vpriv (velaglucerase alfa), an enzyme replacement therapy (ERT), for type 1 Gaucher disease. In 2012, Elelyso (taliglucerase alfa) and in 2014, Cerdelga (eliglustat) was approved by FDA for type 1 Gaucher disease. These drugs offer variety of options based on their requirements, in turn is expected to boost the growth of the market.
In July 2017, The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) collaborated to promote the use of innovative approaches in the development of medicines for Gaucher disease. Such strategic collaboration of regulatory bodies for the development of novel innovative drugs is expected to boost the growth of Gaucher disease treatment market in near future. Lack of awareness regarding the symptoms, diagnosis, and treatment of disease among rural population is a major factor restraining market growth.
North America is expected to hold dominant position due to increasing research activities and drug development for Gaucher disease
North America is expected to hold the dominant position in the Gaucher disease treatment market due to increasing research activities for the development of novel drugs. In 2016, the scientist from National Institutes of Health researchers collaborated with National Institute of Neurological Disorders and Stroke (NINDS) and the National Center for Advancing Translational Sciences (NCATS). Researchers identified a new molecule that shows promising approach for treatment of the rare Gaucher disease. Europe is expected to be the second largest market for Gaucher disease treatment due to the initiative taken by European organizations to spread awareness about Gaucher disease among the population. For instance in 2014, European Gaucher Alliance launched Gaucher Awareness Day aiming to spread awareness about this rare disease among the European population.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/gaucher-disease-treatment-market-1225
Key players operating in global Gaucher disease treatment market include Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc., and Actelion Pharmaceuticals Ltd. (acquired by Johnson & Johnson in June 2017). There are various drugs in pipeline of companies such as Lixte Biotechnology Holdings Inc, JCR Pharmaceuticals Co Ltd, Pharming Group NV and Orphazyme ApS, for Gaucher disease treatment.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gaucher Disease Treatment Market - Global Industry Analysis 2025 here
News-ID: 965385 • Views: …
More Releases from CMI-Research Reports
Corrosion Resistant Resin Market - Global Industry Insights Opportunity Analysis …
Resin is highly viscous or solid substance which can be natural or of synthetic origin. Corrosion resistance resins are mainly formulated as isophthalic, vinyl ester, and terephthalic resins to impart desired property of corrosion resistance. They have application in oil & gas, automotive, and marine industries However, corrosion is major challenges faced by manufactures operating in these industries, as it leads to high monetary and property losses across the aforementioned…
Textile Packaging Market - Global Industry Insights, Trends, Outlook, and Opport …
Packaging textiles comprise all types of textile packing material for industrial, agricultural, and other goods. Textiles are usually preferred as packing materials, where scratch free and safe handling of materials is expected. Textile bags are extensively used for tea packaging. Non-woven textiles offer supreme abrasion resistance, good barrier performance, balanced waterproof properties and air-permeability, excellent tearing and tensile strength, highly uniformed appearance.
Soft luggage bags such as totes, duffle, uprights, and…
Increasing Electrical and Electronics Industry Growth Leading to Augmented Deman …
Gaffers Tape Market Outlook -
Asia Pacific is one of the largest markets for gaffers tape. This is mainly attributed to the rapidly growing construction industry in this region. According to India Brand Equity Foundation (IBEF)—a trust by the Department of Commerce, Ministry of Commerce and Industry, Government of India—,in FY2020 the Indian construction Industry is estimated to reach a value of US$ 5 billion. This inadvertently would boost growth…
Polyvinylidene Fluoride (PVDF) Market - Global Industry Insights, Opportunity An …
Polyvinylidene fluoride (PVDF) is a highly non-reactive thermoplastic fluoropolymer. It is chemically inert to most alcohols, acids, aromatic and aliphatic organic compounds, and chlorinated solvents. It offers properties such as low coefficient of friction, excellent intrinsic fire resistance, operability over a wide range of temperatures, good resistance to UV and radiation, capability for thermoforming, and can be easily joined by welding. Polyvinylidene fluoride is processed by various methods such as…
More Releases for Gaucher
Global Gaucher Disease Drugs Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Gaucher Disease Drugs Market will expand with a CAGR value of 2.1 percent from 2021 to 2026. The Gaucher disease treatment demand is primarily influenced by factors like the rising incidence of disease in both men and women of all ages and the resulting rise in the number of medications available in the marketplace. Also, a growing number of major players…
Gaucher Disease Market Size by 2025: QY Research
This recently published report examines the global Gaucher Disease market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Gaucher Disease market along with its drivers, restraints, and trends. It also classifies the market into different segments such…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Gaucher Disease Treatment Market Intelligence with Competitive Landscape 2025
Gaucher disease is recessive gene dominance disorder with massive clinical heterogeneity. Symptoms of the disease include painless splenomegaly, anemia, or thrombocytopenia, chronic fatigue, hepatomegaly, bone pain, and pathologic fractures. The disease also contributes to easy incidence of bruising and bleeding through the nose. Manifested in three sub-types, the disease results from the deficiency of the enzyme glucocerebrosidase.
It is the most common lysosomal storage disorder and has an incidence of…
United States Gaucher Disease Market Report 2017
In this report, the United States Gaucher Disease market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Gaucher Disease in these…
Global Gaucher Disease Treatment Market
Gaucher disease is recessive gene dominance disorder with massive clinical heterogeneity. Symptoms of the disease include painless splenomegaly, anemia, or thrombocytopenia, chronic fatigue, hepatomegaly, bone pain, and pathologic fractures. The disease also contributes to easy incidence of bruising and bleeding through the nose. Manifested in three sub-types, the disease results from the deficiency of the enzyme glucocerebrosidase. It is the most common lysosomal storage disorder and has an incidence of…
